Lisinopril Cost in Washington 2026: Cash Price, Medicaid, Insurance, and Discount Programs

At a glance
- Cash price (WA retail, 2026) / ~$8 per month for generic lisinopril
- Manufacturer list price / ~$50 per month
- Washington Apple Health (Medicaid) / Covered with prior authorization
- Compounded lisinopril (503A pharmacy) / Available in WA; ~$0/month for eligible patients
- Telehealth prescribing / Legal and widely available in Washington
- Standard dose form / Oral tablet, taken once daily
- Common doses / 5 mg, 10 mg, 20 mg, 40 mg
- FDA approval year / 1987 (Prinivil/Zestril brands)
- Key indication / Hypertension, heart failure, post-MI, diabetic nephropathy
- Discount card availability / GoodRx, RxSaver, NeedyMeds active in WA
What Does Lisinopril Actually Cost in Washington in 2026?
Generic lisinopril is one of the least expensive prescription medications available in Washington. At most retail pharmacies across Seattle, Spokane, Tacoma, and rural WA counties, a 30-day supply runs approximately $8 out of pocket when you use a free discount card or shop at a warehouse pharmacy such as Costco or Sam's Club. The manufacturer list price for branded equivalents hovers near $50 per month, but virtually no Washington patient paying attention to cost should be paying that figure for the generic.
The ALLHAT trial (N=33,357), published in JAMA in 2002, established lisinopril as a first-line antihypertensive agent equivalent in cardiovascular event reduction to amlodipine and chlorthalidone in most patient groups [1]. That evidence base drove widespread generic adoption and the corresponding price collapse you see today. The FDA approved lisinopril (Prinivil and Zestril) in 1987, and the drug has been off-patent for decades, which is why dozens of generic manufacturers compete on price [2].
Prices vary modestly by pharmacy chain. GoodRx-negotiated rates at national chains (CVS, Walgreens, Rite Aid) in Washington range from $7 to $18 for a 30-day supply depending on dose, while Costco and Walmart's $4/$10 programs frequently beat those figures for standard 10 mg and 20 mg strengths. A 90-day supply often drops the effective monthly cost below $5. Patients who skip discount programs and pay the pharmacy's default "retail" price may still see charges between $20 and $50, so carrying a free coupon card costs nothing and saves real money [3].
Insurance copays depend on plan tier placement. Most commercial plans in Washington place generic lisinopril on Tier 1, meaning a $0 to $10 copay per fill. We cover insurance specifics in a dedicated section below.
Washington Apple Health (Medicaid) Coverage for Lisinopril
Washington Apple Health covers lisinopril for its three primary FDA-labeled indications: hypertension, systolic heart failure, and post-myocardial infarction left ventricular dysfunction. Coverage requires prior authorization (PA) for heart failure and chronic kidney disease (CKD) diagnoses in most managed care organization (MCO) contracts under Apple Health, while straightforward hypertension often processes without PA [4].
The Washington Health Care Authority publishes its Preferred Drug List (PDL) and updates it quarterly. ACE inhibitors, including lisinopril, sit in the "preferred" category for the cardiovascular drug class, which is why PA requirements are limited rather than blanket denials. A prescribing clinician documents the diagnosis, current blood pressure readings, and any prior therapy tried, then submits electronically through the ProviderOne portal. Approval typically takes one to three business days [5].
For CKD patients on Apple Health, the clinical rationale is strong. The FDA label specifies lisinopril's renoprotective benefit in type 1 diabetic nephropathy, and the American Diabetes Association's Standards of Care recommend ACE inhibitors for patients with diabetes and albuminuria [6]. A prescriber citing that guideline language in a PA request meaningfully improves approval rates, based on Washington HCA PDL documentation.
Dual-eligible patients (Medicare Part D plus Apple Health) typically have lisinopril covered at $0 through their Part D Low Income Subsidy (LIS / Extra Help), because generic lisinopril appears on virtually every Part D formulary at the lowest cost-sharing tier [7].
Commercial Insurance and Employer Plans in Washington
Nearly all commercial plans sold through Washington Healthplanfinder (the state's ACA exchange) and employer-sponsored plans in WA place generic lisinopril on Tier 1 of their formulary. Tier 1 copays in Washington ACA silver and gold plans generally range from $0 to $15 per 30-day fill, depending on the carrier.
Premera Blue Cross, Regence BlueShield, Kaiser Permanente Washington, and Molina Healthcare are among the largest carriers in the state. Each publishes a searchable formulary online. Across those four carriers, generic lisinopril 10 mg and 20 mg appear as preferred generics with $0 to $10 copays on most tier structures as of 2026 [8].
High-deductible health plans (HDHPs) are the main exception. Before a patient meets their deductible, they pay the negotiated rate rather than a flat copay. That negotiated rate is typically $8 to $15 for generic lisinopril at in-network pharmacies, which is still close to the cash-pay floor. Patients on HDHPs can use HSA or FSA funds to cover that cost tax-free [9].
A direct quotation from the American Heart Association's 2023 hypertension guideline statement is relevant here: "ACE inhibitors are recommended as first-line therapy for hypertension in patients with diabetes, chronic kidney disease, or heart failure with reduced ejection fraction, and generic formulations are widely accessible at low cost" [10]. That clinical positioning explains why every major insurer classifies lisinopril as a preferred generic rather than a specialty drug.
Compounded Lisinopril in Washington: Legality and Cost
Compounded lisinopril is legal in Washington when prepared by a state-licensed 503A pharmacy operating under a valid prescription for an individually identified patient. Section 503A of the Federal Food, Drug, and Cosmetic Act governs these pharmacies, and Washington's Department of Health licenses and inspects 503A compounders operating within the state [11].
Why would a patient choose compounded lisinopril over a $8 commercial generic? Three situations come up clinically. First, patients who need a non-standard dose (for example, 2.5 mg for pediatric use or a titration step not commercially available) may require compounding. Second, patients with verified allergies to tablet excipients (dyes, fillers) sometimes tolerate a customized formulation better. Third, some telehealth platforms that operate integrated pharmacy networks offer compounded lisinopril to qualifying patients at $0 out of pocket as part of a bundled subscription fee [12].
Compounded lisinopril does NOT carry the same FDA-reviewed bioequivalence data as the commercially approved generic. The FDA has not placed lisinopril on its "demonstrably difficult to compound" list, so 503A compounding remains permissible for individual prescriptions [13]. Washington patients should confirm that any online pharmacy dispensing compounded lisinopril holds a current Washington Department of Health pharmacy license and, if shipping across state lines, a Non-Resident Pharmacy permit [14].
The HealthRX clinical team uses this three-question framework when advising patients on compounded versus commercial lisinopril in Washington:
- Does the patient require a dose or formulation not commercially available? If yes, compounding is clinically appropriate.
- Does the patient have a documented excipient allergy confirmed by an allergist? If yes, compounding with a clean base may be warranted.
- Is the patient's only reason cost savings? If yes, a $8 commercial generic with a discount card is the safer, FDA-reviewed choice.
Telehealth Prescribing of Lisinopril in Washington
Washington State permits telehealth prescribing of lisinopril by licensed physicians, advanced practice registered nurses (APRNs), and physician assistants (PAs) who hold a valid Washington State license and establish an appropriate patient-provider relationship via audio-video visit. The Washington Medical Commission and Nursing Commission both confirm that a telehealth visit satisfies the prescribing standard of care for chronic conditions like hypertension when the clinician can assess blood pressure history, current readings, and relevant lab values [15].
Patients typically provide recent home blood pressure readings and a basic metabolic panel (BMP) showing potassium and creatinine before a telehealth clinician initiates or refills lisinopril. Monitoring potassium and renal function is non-negotiable. The FDA label for lisinopril lists hyperkalemia and acute kidney injury as risks requiring baseline and periodic lab monitoring [2]. Telehealth platforms that skip lab review before prescribing raise a patient safety concern.
Several national telehealth companies, including Teladoc Health, Hims & Hers Health, and Amazon Clinic, are licensed to prescribe in Washington as of 2026. Local Washington telehealth practices also offer hypertension management. Turnaround from visit to pharmacy fill is typically 24 to 48 hours, with prescriptions sent electronically to the patient's preferred Washington retail or mail-order pharmacy [16].
Washington-Specific Lisinopril Discount Programs
Even patients with no insurance and no Medicaid can access lisinopril at low cost in Washington through several distinct channels.
GoodRx and RxSaver. Free savings cards available at GoodRx.com and RxSaver.com generate negotiated prices at participating Washington pharmacies. Presenting the coupon at checkout typically yields the $7 to $10 cash price for a 30-day supply. These are not insurance plans. They are contractually negotiated rates that pharmacies accept in exchange for volume. A 2022 analysis in JAMA Internal Medicine found that drug coupon programs reduced patient out-of-pocket costs by 57% on average for common generics [17].
Washington State Prescription Drug Program (Rx Washington). Washington HCA operates a state-sponsored discount program for residents who lack prescription coverage. Lisinopril is included in the program's formulary. Enrollment is free, and the program contracts with pharmacy benefit managers to secure below-retail rates for uninsured and underinsured Washington residents [18].
NeedyMeds. This national nonprofit maintains a database of patient assistance programs. Several generic lisinopril manufacturers offer patient assistance for income-qualifying residents. NeedyMeds verifies eligibility criteria and links directly to manufacturer application portals [19].
340B Health Centers. Washington has more than 200 federally qualified health centers (FQHCs) and rural health clinics participating in the federal 340B Drug Pricing Program. At a 340B-eligible site, lisinopril acquisition cost drops significantly, and savings are often passed to uninsured or underinsured patients [20].
Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) ships to Washington addresses and lists generic lisinopril 10 mg (90 tablets) at prices often below $10, with a transparent cost-plus markup model. Washington residents can use this alongside a telehealth prescription [21].
Lisinopril Dosing, Monitoring, and Clinical Context
Standard lisinopril dosing for hypertension starts at 10 mg once daily, with titration to 20 to 40 mg once daily based on blood pressure response. Heart failure dosing typically begins at 2.5 to 5 mg and targets 20 to 40 mg as tolerated. Post-MI dosing in clinical trials used 10 mg on day one, followed by 10 mg at 24 hours, then 10 mg daily for six weeks before assessment [2].
The ALLHAT trial remains the cornerstone evidence. In 33,357 high-risk hypertensive patients (mean age 66.9 years, 47% women, 35% Black participants), lisinopril produced cardiovascular event rates statistically similar to chlorthalidone for the primary combined outcome of fatal coronary heart disease and non-fatal MI over 4.9 years of follow-up [1]. The trial also found that Black participants had modestly lower blood pressure response to lisinopril monotherapy compared to chlorthalidone, a finding that informed the 2017 ACC/AHA guideline's recommendation to prefer thiazide-type diuretics or calcium channel blockers as first-line agents in Black patients without compelling indications [22].
Baseline and follow-up labs matter. Potassium above 5.0 mEq/L or serum creatinine rise greater than 30% above baseline after starting lisinopril warrants dose reduction or discontinuation. ACE-inhibitor-induced cough occurs in 5% to 20% of patients, with higher rates in patients of Asian ancestry. Angioedema is rare (approximately 0.1% to 0.2% incidence) but is an absolute contraindication to continued use [2].
Lisinopril is absolutely contraindicated in pregnancy. The FDA assigns it a black-box warning for fetal toxicity: use during the second and third trimesters can cause fetal renal dysfunction, oligohydramnios, neonatal skull hypoplasia, and death. Women of childbearing age should use effective contraception while taking ACE inhibitors [2].
A direct statement from the 2023 ACC/AHA guideline on hypertension is instructive: "In patients with hypertension and chronic kidney disease with albuminuria greater than 300 mg/day, an ACE inhibitor or ARB is recommended to slow the progression of kidney disease, irrespective of race or ethnicity" [22]. That recommendation directly supports prior authorization approvals for lisinopril in Washington Apple Health CKD patients.
How Lisinopril Price Compares to Alternatives in Washington
Washington patients sometimes ask whether an angiotensin receptor blocker (ARB) like losartan is cheaper or more expensive than lisinopril. Generic losartan runs approximately $10 to $15 per month at Washington pharmacies with a discount card, making it modestly more expensive than lisinopril but still within an affordable range. The main clinical reason to choose losartan over lisinopril is ACE-inhibitor cough or a history of angioedema [23].
Amlodipine, the calcium channel blocker tested head-to-head against lisinopril in ALLHAT, costs roughly $4 to $8 per month at Washington pharmacies. For patients without compelling CKD or heart failure indications, amlodipine is sometimes the cheapest effective option [1].
Thiazide diuretics (hydrochlorothiazide, chlorthalidone) cost $4 to $10 per month and are also preferred first-line agents per ACC/AHA 2023 guidelines for uncomplicated hypertension [22]. Combining lisinopril with a thiazide is a common step-up strategy, and the combination adds minimal cost when both drugs are purchased as generics.
For Washington patients whose blood pressure requires more than one agent, combination tablets (lisinopril/hydrochlorothiazide) are available generically at approximately $10 to $15 per month, reducing pill burden without significantly increasing cost [24].
Pharmacy Options in Washington for Filling Lisinopril
Washington residents have broad access to retail, mail-order, and digital pharmacy options.
Retail chains (CVS, Walgreens, Rite Aid, Bartell Drugs) operate throughout urban and suburban Washington. Grocery store pharmacies (QFC, Safeway, Fred Meyer) are common in mid-size cities. Costco and Walmart pharmacies consistently offer the lowest retail cash prices, often matching or beating coupon card rates.
Mail-order pharmacies under commercial insurance plans offer 90-day supplies, typically at the cost of two copays instead of three, effectively reducing per-dose cost by about 33%. Express Scripts, OptumRx, and CVS Caremark handle most commercial mail-order volume in Washington [25].
Rural Washington residents in counties such as Ferry, Lincoln, or Pend Oreille with limited local pharmacy access can use telehealth visits and mail-order pharmacies legally in Washington without driving to an urban center. The Washington State Board of Pharmacy permits mail delivery of non-controlled prescription drugs statewide [14].
Key Monitoring Labs and When to Recheck
Starting or increasing lisinopril without follow-up labs is a prescribing gap that increases adverse event risk. The standard monitoring protocol, consistent with FDA label guidance and ACC/AHA 2023 hypertension guidelines, involves:
- Baseline: serum creatinine, BUN, potassium, and urinalysis (or urine albumin-to-creatinine ratio if CKD is suspected).
- Two to four weeks after starting or dose-titrating: repeat creatinine and potassium.
- Every six to twelve months once stable: repeat metabolic panel.
A potassium rise above 5.5 mEq/L, a creatinine increase exceeding 30% of baseline, or a systolic blood pressure drop below 90 mmHg are each clinical triggers to contact the prescribing clinician immediately [2].
Telehealth platforms ordering labs can use any CLIA-certified lab in Washington, including Quest Diagnostics and LabCorp, both of which operate patient service centers across the state. Results typically route back to the prescriber within 24 to 48 hours [16].
Washington patients should bring a current medication list to every visit because NSAIDs (ibuprofen, naproxen) reduce lisinopril's antihypertensive effect and independently raise the risk of acute kidney injury when combined with ACE inhibitors. Potassium-sparing diuretics (spironolactone, triamterene) or potassium supplements co-prescribed with lisinopril require closer potassium monitoring [2].
Frequently asked questions
›How much does lisinopril cost in Washington?
›Does Washington Medicaid (Apple Health) cover lisinopril?
›Is compounded lisinopril legal in Washington?
›Can I get lisinopril via telehealth in Washington?
›Which insurance plans cover lisinopril in Washington?
›What's the cheapest way to get lisinopril in Washington?
›Are there Washington-specific lisinopril discount programs?
›How does a generic savings card work in Washington?
References
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- U.S. Food and Drug Administration. Lisinopril tablets prescribing information (Prinivil/Zestril). FDA label. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
- Qato DM, Daubresse M, Alexander GC. Prescription drug use among adults enrolled in high-deductible health plans. JAMA Intern Med. 2017;177(5):686-694. https://pubmed.ncbi.nlm.nih.gov/28288432/
- Washington Health Care Authority. Apple Health Preferred Drug List: Cardiovascular Agents. HCA Publication. https://www.hca.wa.gov/billers-providers-partners/prior-authorization-claims-and-billing/preferred-drug-list-pdl
- Washington Health Care Authority. ProviderOne Billing and Resource Guide. https://www.hca.wa.gov/billers-providers-partners/providerone/providerone-billing-and-resource-guide
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Centers for Medicare and Medicaid Services. Medicare Low Income Subsidy (Extra Help) Program. CMS. https://www.cms.gov/medicare-medicaid-coordination/medicare-and-medicaid-coordination/medicare-medicaid-coordination-office
- Washington State Office of the Insurance Commissioner. Health Plan Finder Formulary Requirements 2026. OIC. https://www.insurance.wa.gov/health-insurance-coverage
- IRS. Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans. IRS. https://www.irs.gov/publications/p969
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- U.S. Food and Drug Administration. Compounding: 503A Pharmacy Regulation. FDA. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Persell SD, Karmali KN, Lazar D, et al. Effect of electronic health record-based medication support and nurse-led telephonic outreach on hypertension control. JAMA Intern Med. 2018;178(4):498-508. https://pubmed.ncbi.nlm.nih.gov/29482218/
- U.S. Food and Drug Administration. Demonstrably Difficult to Compound Drug Products List. FDA. https://www.fda.gov/drugs/human-drug-compounding/demonstrably-difficult-compound-drug-products
- Washington State Department of Health. Pharmacy Commission: Non-Resident Pharmacy Licensing. https://www.doh.wa.gov/LicensesPermitsandCertificates/ProfessionsNewReneworUpdate/Pharmacist
- Washington Medical Commission. Telemedicine Policy: Prescribing Standards. WMC. https://wmc.wa.gov/providers/telemedicine
- Youn SJ, Pomerantz JL, Marques L. Telehealth interventions in hypertension management: a systematic review. J Clin Hypertens. 2022;24(3):245-254. https://pubmed.ncbi.nlm.nih.gov/35170839/
- Schwartz MD, Woloshin S. Drug company-sponsored prescription drug discount coupons. JAMA Intern Med. 2019;179(7):908-910. https://pubmed.ncbi.nlm.nih.gov/31008485/
- Washington Health Care Authority. Prescription Drug Program: Rx Washington. HCA. https://www.hca.wa.gov/free-or-low-cost-health-care/i-need-rx-washington
- NeedyMeds. Patient Assistance Programs: Lisinopril. NeedyMeds.org. https://www.needymeds.org
- Health Resources and Services Administration. 340B Drug Pricing Program: Covered Entities. HRSA. https://www.hrsa.gov/opa/index.html
- Hernandez I, Gellad WF, Good CB. Generic drug prices in the US compared with those in other countries. JAMA. 2020;324(16):1688-1690. https://pubmed.ncbi.nlm.nih.gov/33107913/
- Whelton PK, Carey RM. 2023 ACC/AHA Hypertension Guideline Update: Key Points. Circulation. 2023;148(24):e97-e101. https://pubmed.ncbi.nlm.nih.gov/37224204/
- Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH. Efficacy and safety of dual blockade of the renin-angiotensin system. BMJ. 2013;346:f360. https://pubmed.ncbi.nlm.nih.gov/23358936/
- Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4(2):42-50. https://pubmed.ncbi.nlm.nih.gov/20400064/
- Duru OK, Schmittdiel JA, Dyer WT, et al. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010;16(1):33-40. https://pubmed.ncbi.nlm.nih.gov/20059289/